Utilizing a Lenti-Cre-Cas9–single guide RNA (sgRNA) approach for targeted deletion in the respiratory epithelium, we evaluated the impact of Trp53 and Pten tumor suppressor deletions in Sox2-mediated NSCLC on tumor progression, TME composition, and tumor cell differentiation. This evidence concerns the gene SOX2 and non-small cell lung carcinoma.